ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 43 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4 | -33.3% | 34,500 | 0.0% | 0.00% | – |
| Q4 2022 | $6 | -99.9% | 34,500 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | -58.8% | 34,500 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -15.0% | 34,500 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -4.8% | 34,500 | 0.0% | 0.00% | – |
| Q4 2021 | $21,000 | -36.4% | 34,500 | 0.0% | 0.00% | – |
| Q3 2021 | $33,000 | -13.2% | 34,500 | 0.0% | 0.00% | – |
| Q2 2021 | $38,000 | +18.8% | 34,500 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | +88.2% | 34,500 | 0.0% | 0.00% | – |
| Q4 2020 | $17,000 | -56.4% | 34,500 | -31.0% | 0.00% | – |
| Q3 2020 | $39,000 | +44.4% | 50,000 | 0.0% | 0.00% | – |
| Q2 2020 | $27,000 | +50.0% | 50,000 | 0.0% | 0.00% | – |
| Q1 2020 | $18,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |